A study of peginterferon alfa-2a in combination with ribavirin in chronic hepatitis C(CHC) patients with compensated liver cirrhosis(LC)

Authors
Category Primary study
Year 2006
INTERVENTION: Intervention name : Peginterferon alpha‐2a and ribavirin Dosage And administration of the intervention : Peginterferon alpha‐2a: Subcutaneous injection Ribavirin: Oral CONDITION: CHC with compensated LC PRIMARY OUTCOME: Efficacy and safety INCLUSION CRITERIA: Male and Female patients aged 20 to 75 years‐old, diagnosed CHC with compensated LC, elevated ALT and detectable HCV RNA.
Epistemonikos ID: dc1cdccf90aca3bacac0890fdecc6a1c08df3656
First added on: Aug 21, 2024